ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $618,734 | -27.9% | 25,410 | 0.0% | 0.00% | – |
Q1 2024 | $858,096 | +7.1% | 25,410 | 0.0% | 0.00% | – |
Q4 2023 | $801,177 | +23.4% | 25,410 | 0.0% | 0.00% | – |
Q3 2023 | $649,226 | -72.1% | 25,410 | -68.7% | 0.00% | -100.0% |
Q2 2023 | $2,325,088 | +325.4% | 81,070 | +255.6% | 0.00% | – |
Q1 2023 | $546,516 | +41.3% | 22,800 | 0.0% | 0.00% | – |
Q4 2022 | $386,688 | +14.4% | 22,800 | 0.0% | 0.00% | – |
Q3 2022 | $338,000 | -17.8% | 22,800 | -12.6% | 0.00% | – |
Q2 2022 | $411,000 | -41.6% | 26,100 | 0.0% | 0.00% | – |
Q1 2022 | $704,000 | -27.1% | 26,100 | 0.0% | 0.00% | – |
Q4 2021 | $966,000 | -22.5% | 26,100 | 0.0% | 0.00% | – |
Q3 2021 | $1,247,000 | +22.4% | 26,100 | -13.3% | 0.00% | – |
Q2 2021 | $1,019,000 | -18.0% | 30,100 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $1,243,000 | -4.8% | 30,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,306,000 | +89.0% | 30,100 | +87.0% | 0.00% | – |
Q3 2020 | $691,000 | -11.5% | 16,100 | -3.6% | 0.00% | – |
Q2 2020 | $781,000 | – | 16,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 204,673 | $10,164,000 | 6.19% |
CVI Holdings, LLC | 200,032 | $9,349,000 | 3.47% |
DAFNA Capital Management LLC | 149,017 | $6,965,000 | 2.01% |
Cormorant Asset Management, LP | 800,000 | $37,392,000 | 1.43% |
ARK Investment Management | 1,918,835 | $89,686,000 | 0.96% |
EAM Global Investors LLC | 30,948 | $1,447,000 | 0.65% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,362,000 | 0.61% |
Monashee Investment Management LLC | 79,497 | $3,716,000 | 0.56% |
EAM Investors, LLC | 40,695 | $1,902,000 | 0.42% |
Diametric Capital, LP | 11,478 | $536,000 | 0.41% |